首页 | 本学科首页   官方微博 | 高级检索  
检索        

GCLM C-588T多态与中国人冠状动脉粥样硬化性心脏病遗传易感性的关系
引用本文:左洪鹏,徐文俊,罗明,朱忠政,朱冠山.GCLM C-588T多态与中国人冠状动脉粥样硬化性心脏病遗传易感性的关系[J].同济大学学报(医学版),2006,27(3):51-54.
作者姓名:左洪鹏  徐文俊  罗明  朱忠政  朱冠山
作者单位:1. 同济大学附属同济医院心血管内科,上海,200065
2. 解放军第113医院病理科,浙江,宁波,315040
3. 上海基康生物技术服务有限公司,上海,200122
摘    要:目的 探讨谷氨酸-半胱氨酸连接酶修饰亚单位基因(glutarnat-cysteine ligase modifier subunit gene,GCLM)C-588T多态与中国人冠状动脉粥样硬化性心脏病(coronary heart disease,CHD)遗传易感性的关系。方法 采用聚合酶链反应-限制性片段长度多态方法,检测209例CHD与240名对照的GCLM基因型分布及差异。结果 CHD组及对照组T等位基因频率分别为17.2%及26.3%,T的CHD发病风险是C的0.59倍(95%CI=0.42-0.81。P=0.001)。与C/C纯合子相比,C/T杂合子引起CHD风险为0.67倍(95%CI=0.45~1.01,P=0.056),而T/T纯合子引起CHD风险度显著降低至0.20倍(95%CI=0.06-0.61,P=0.005)。结论 GCLM-588T降低CHD发病风险,提示T/T基因型是中国人CHD的一个遗传保护因素。

关 键 词:冠状动脉粥样硬化性心脏病  遗传易感性  多态性
文章编号:1008-0392(2006)03-0051-04
收稿时间:2006-02-21
修稿时间:2006年2月21日

Association of GCLM C-588T Polymorphism with Genetic Susceptibility to Coronary Heart Disease in Chinese Population
ZUO Hong-peng,XU Wen-jun,LUO Ming,ZHU Zhong-zheng,ZHU Guan-shan of Cardiology,Tongji Hospital,Affiliated to Tongji University,Shanghai,China; . Dept. of Pathology,No. Hospital of PLA,Ningbo,China; . Shanghai GeneCore Biotech.Association of GCLM C-588T Polymorphism with Genetic Susceptibility to Coronary Heart Disease in Chinese Population[J].Journal of Tongji University(Medical Science),2006,27(3):51-54.
Authors:ZUO Hong-peng  XU Wen-jun  LUO Ming  ZHU Zhong-zheng  ZHU Guan-shan of Cardiology  Tongji Hospital  Affiliated to Tongji University  Shanghai  China; Dept of Pathology  No Hospital of PLA  Ningbo  China; Shanghai GeneCore Biotech
Institution:ZUO Hong-peng,XU Wen-jun,LUO Ming,ZHU Zhong-zheng,ZHU Guan-shan of Cardiology,Tongji Hospital,Affiliated to Tongji University,Shanghai,China; . Dept. of Pathology,No. Hospital of PLA,Ningbo,China; . Shanghai GeneCore Biotech
Abstract:Objective To investigate the possible association of the glutamate-cysteine ligase modifier subunit gene(GCLM) C-588T polymorphism with coronary heart disease(CHD) in a Chinese population.Methods For 209 CHD cases and 240 unrelated health individuals,GCLM C-588T genotypes were determined using a PCR-based restriction fragment length polymorphism(RFLP) method.Odds ratios(ORs) for HCC and 95% confidence intervals(CIs) from unconditional logistic regression models were used to evaluate relative risks.Results The frequency of T allele was 0.172 in CHD cases and 0.263 in controls,respectively.The T allele had a significantly decreased risk for CHD(OR=0.59,95% CI=0.42-0.81,P=0.001) in comparison with the C allele.Compared to C/C homozygote,C/T heterozygote had a 0.67-fold decreased risk(95% CI=0.45-1.01,P=0.056),whereas T/T homozygote had a 0.20-fold significantly decreased risk(95% CI=0.06-0.61,P=0.005) of CHD.Conclusion The T allele of GCLM C-588T is associated with the decreased risk of CHD and T/T homozygote is potentially one of the protective factors for CHD in Chinese population.
Keywords:GCLM
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《同济大学学报(医学版)》浏览原始摘要信息
点击此处可从《同济大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号